Robert Ford - Abbott Laboratories Pres Chairman

ABL Stock  EUR 112.24  2.56  2.33%   

Insider

Robert Ford is Pres Chairman of Abbott Laboratories
Age 49
Phone224 667 6100
Webhttps://www.abbott.com

Abbott Laboratories Management Efficiency

The company has return on total asset (ROA) of 0.0738 % which means that it generated a profit of $0.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1901 %, meaning that it generated $0.1901 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.
Abbott Laboratories has accumulated 14.52 B in total debt with debt to equity ratio (D/E) of 0.55, which is about average as compared to similar companies. Abbott Laboratories has a current ratio of 1.72, which is within standard range for the sector. Debt can assist Abbott Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Abbott Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbott Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbott to invest in growth at high rates of return. When we think about Abbott Laboratories' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Robert SmithNMI Holdings
53
Fei WangOrigin Agritech
40
Bjorn NorrbomSIVERS SEMICONDUCTORS AB
72
Edward KirnbauerIdentiv
58
Torsten LeueTalanx AG
57
Robert GreenSIVERS SEMICONDUCTORS AB
60
Ash RajendraSuperior Plus Corp
N/A
Justin ScarpullaIdentiv
50
Vamsi PudipeddiAlign Technology
51
Mohammad YousafNMI Holdings
47
Min TangOrigin Agritech
61
Emory WrightAlign Technology
53
Manfred MuellerIdentiv
53
James DevensSuperior Plus Corp
N/A
Caroline SchlienkampTalanx AG
49
Shirley StacyAlign Technology
N/A
Erik WiklundSIVERS SEMICONDUCTORS AB
49
Amir KhoshniyatiIdentiv
N/A
Sven PetterssonSIVERS SEMICONDUCTORS AB
60
Jennifer OlsonWilkAlign Technology
45
Patric ErlandssonSIVERS SEMICONDUCTORS AB
51
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT LABS operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 109000 people. Abbott Laboratories (ABL) is traded on Frankfurt Exchange in Germany and employs 115,000 people.

Management Performance

Abbott Laboratories Leadership Team

Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Leinenweber, Licensing Relations
Robert Ford, Pres Chairman
James Young, VP Officer
Elaine Leavenworth, VP Officer
Mary Moreland, Ex HR
Robert Funck, Exec CFO
Daniel Salvadori, Ex Products
Andrea Wainer, Ex Diagnostics
Hubert Allen, Gen VP
Melissa Brotz, VP Marketing

Abbott Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abbott Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Abbott Stock

When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.